Home / US Department of Health and Human Services / PAR-25-336

Toward Translation of Nanotechnology Cancer Interventions (TTNCI; R01 Clinical Trial Not Allowed)

Open now · Grant · PAR-25-336

Check my fit, free Open the official call ↗

Next cut-off

15 Nov '27

in 435 days

Call budget

across every grant here

Grants expected

not published for this call

Funding rate

not published, read the conditions

What this call funds

Through this Notice of Funding Opportunity (NOFO), entitled "Toward Translation of Nanotechnology Cancer Interventions" (TTNCI), the National Cancer Institute (NCI) encourages applications for advanced pre-clinical research, supporting translation of nanotechnology-based cancer diagnostics and therapeutics. TTNCI awards are designed to mature experimental nanomedicines relying on nanoparticles and nano-devices which demonstrate strong potential to improve cancer treatment effectiveness due to the combination of nanoparticle/nano-device structural design and/or therapeutic/diagnostic cargo which is delivered. TTNCI awards are expected to enable further development of proposed nanotechnology-based interventions to the stage in which they could continue on a developmental path towards the NCI Experimental Therapeutics (NExT) and other NCI translational programs.

What applying costs you

Item	Estimate	Note
Drafting effort	3–4 weeks	single submission
Time to first payment	6–9 months	cut-off → evaluation → grant agreement

These are Bemzu's estimates from the call's structure (the number of stages and whether a consortium is required) not figures published by the Commission. Only the co-financing share is read from the call itself.

Also open in HHS

CallNext cut-offPer grant

Cellular and Molecular Biology of Complex Brain Disorders (R01 Clinical Trial Not Allowed)PAR-25-038 · US Department of Health and Human Services · single applicant* 07 Sept '26in 1d , not published Alcohol Treatment, Pharmacotherapy, and Recovery Research (R34 Clinical Trial required)PAR-25-193 · US Department of Health and Human Services · single applicant* 07 Sept '26in 1d , not published Social disconnection and Suicide Risk in Late Life (R21 Clinical Trial Optional)PAR-25-066 · US Department of Health and Human Services · single applicant* 07 Sept '26in 1d , not published Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer's Dementia (R21 Clinical Trial Optional)PAR-25-064 · US Department of Health and Human Services · single applicant* 07 Sept '26in 1d , not published Schizophrenia and related disorders during mid- to late-life (R01 Clinical Trial Optional)PAR-25-039 · US Department of Health and Human Services · single applicant* 07 Sept '26in 1d , not published

Become the beneficiary.

Eight questions, no account, nothing sent anywhere. You will know which of the 1526 open calls you can actually enter before you finish your coffee.

Check my fit